Abstract:Introduction: Melanoma ranks 19th among malignancies overall and second among cutaneous types. The incidence worldwide has been on the rise over the last seven decades. Various prognostic factors have been assessed and found to have a profound impact on patient outcome. However, no such studies have been attempted in our population. Our study aimed to have an insight into the behavior of malignant melanoma in our population. Materials and methods: Cases of cutaneous malignant melanoma treated and followed up at our institute were included in this study. Cases of mucosal and choroidal melanoma were excluded. The parameters noted were age, gender, tumor thickness, Clark level, and presence of ulceration. These parameters were individually correlated with development of distant metastasis, two-year survival, survival duration, and primary tumor and lymph node stage. Appropriate statistical analyses were done. Results: Thirty patients of cutaneous malignant melanomas were treated and followed up at our institution. There was male predilection of 1:1.5. Mean age at diagnosis was 50.1 years. Two-year survival was significantly better in females. Sun-exposed areas of the skin were most commonly involved followed by anal canal that has an unusually high incidence in our society. Majority of our cases were pT4(25) on tumor, nodal status, metastasis (TNM) staging at time of diagnosis. Increasing tumor thickness in terms of primary tumor staging was not found to have any significant impact on two-year survival, distant metastasis, lymph node stage, or survival duration. Sixty percent of cases had ulceration. There was no statistically significant effect on two-year survival (78% in ulcerated group vs 75% in nonulcerated group) and distant metastasis (61% vs 58.3%). In terms of Clark level, 20 cases were level V, seven cases were level IV, two were level III, and one was level I. There was no statistically significant difference between the Clark levels in terms of two years survival, development of distant metastasis, and lymph node stages. Conclusion: Melanoma is an aggressive malignancy that causes high morbidity and morality. It commonly presents at an advanced stage at time of diagnosis in our population. Broader studies are required with early-stage melanomas to compare the various prognostic factors and their impact on prognosis.

Evaluation of Demographic and Clinical Characteristics of Turkish Patients With Primary Cutaneous Melanoma: A 5-Year Experience of a Tertiary Referral Center

Clinicopathologic Features of Cutaneous Malignant Melanoma and Their Impact on Prognosis

Cutaneous Malignancies: A Prospective Study of Demographic Patterns, Risk Factors, and Clinical Spectrum at a Tertiary Care Center in South India

A Clinical Characters and Prognosis Analysis on 357 Cases with Cutaneous Malignant Melanoma in China

Cutaneous Malignant Melanoma:Clinicopathological Analysis of 70 Cases

Cutaneous melanoma in adolescents and young adults

Epidemiology and Survival Outcomes for Eyelid Primary Malignant Melanoma: an Analysis of 1397 Cases in the SEER Database

Investigation of Prognostic Factors for Non-Sentinel Lymph Node Metastasis in Patients Undergoing Sentinel Lymph Node Biopsy for Cutaneous Malignant Melanoma: Experience from a Reference Center in Turkey

Clinical Experience from a Single Italian Center

A Ten-Year Literature Review Of Oral Malignant Melanoma Cases: A Meta-Analysis Study

Long-Term survival across breslow thickness categories: Findings from a Population-Based study of 210,042 Australian melanoma patients

Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations

Analysis of the expression of cytokines and chemokines, platelet-leukocyte aggregates, sCD40L and sCD62P in cutaneous melanoma

Analysis and prediction of 5-year survival in patients with cutaneous melanoma: a model-based period analysis

Pediatric melanoma incidence and survival: a fifteen-year nationwide retrospective cohort study in Korea (2004-2019)

Pediatric melanoma incidence and survival: a fifteen-year nationwide retrospective cohort study in Korea (2004–2019)

Melanoma in China: A Prognostic Study of 522 Cases.

A Narrative Review of Current Knowledge on Cutaneous Melanoma

Melanoma: Diagnosis and Treatment

Time trends in incidence and mortality of cutaneous melanoma in Germany

An Italian Multi-Centric Retrospective Experience